发现好书期刊,享受阅读乐趣

海量图书期刊资源,随时随地畅享阅读乐趣

L03Ramucirumab (RAM) as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) Following First-Line Therapy with Sorafenib: Analyses from the Randomized Phase III REACH Study

L03Ramucirumab (RAM) as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) Following First-Line Therapy with Sorafenib: Analyses from the Randomized Phase III REACH Study

Barone, C.; Brandi, G.; Daniele, B.; Villa, E.; Leo, S.; Di Fabio, F.; Aprile, G.; Colombo, M.; Sobrero, A.; Giannelli, G.; Porta, C.; Cabibbo, G.; Zhu, A.; Blanc, J.; Okusaka, T.; Chau, I.; Abada, P.; Yang, L.; Pastorelli, D.
  • 期刊名称Annals of Oncology
  • 作者Barone, C.; Brandi, G.; Daniele, B.; Villa, E.; Leo, S.; Di Fabio, F.; Aprile, G.; Colombo, M.; Sobrero, A.; Giannelli, G.; Porta, C.; Cabibbo, G.; Zhu, A.; Blanc, J.; Okusaka, T.; Chau, I.; Abada, P.; Yang, L.; Pastorelli, D.
  • 卷第26卷
  • 印刷ISSN0923-7534
  • 电子ISSN1569-8041
  • 文件大小37.65KB
  • 发表时间2015-10
  • DOI10.1093/annonc/mdv344.03
← 返回【学霸图书馆】主页